<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
RXST
RxSight
$
()


  • RxSight management to meet with Needham

    9/10/2024 - 04:55am
  • RxSight management to meet with BTIG

    9/9/2024 - 13:15pm
  • RxSight management to meet with Needham

    9/9/2024 - 13:15pm
  • Needham ups RxSight target to $66, adds to Conviction List

    8/20/2024 - 08:54am
  • RxSight price target lowered by $7 at Oppenheimer, here's why

    8/6/2024 - 07:28am
  • RxSight price target lowered by $5 at Stifel, here's why

    8/6/2024 - 06:58am
  • Closing Bell Movers: Lumen surges after securing $5B in new business

    8/5/2024 - 18:21pm
  • RxSight raises FY24 revenue view to $139M-$140M from $132M-$137

    8/5/2024 - 16:47pm
  • RxSight reports Q2 adjusted EPS 0c, consensus (22c)

    8/5/2024 - 16:42pm
  • RxSight price target raised by $1 at BTIG, here's why

    7/15/2024 - 07:21am
  • RxSight price target lowered by $5 at Stifel, here's why

    7/10/2024 - 08:11am
  • RxSight 1.79M share Spot Secondary priced at $56.00

    5/8/2024 - 21:39pm
  • RxSight $100M Spot Secondary; price range $56.00-$57.00

    5/8/2024 - 16:22pm
  • RxSight announces $100M common stock offering

    5/8/2024 - 16:10pm
  • RxSight files automatic mixed securities shelf

    5/8/2024 - 16:03pm
dynamic_feed Breaking News